Understanding the grapefruit-drug interaction

General Dentistry

Volumn 53, Issue 4, 2005, Pages 282-285

  Flanagan, Dennis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; FLAVONOID; GLYCOPROTEIN P; HYPNOTIC SEDATIVE AGENT; PSORALEN DERIVATIVE;

ARTICLE; BINDING COMPETITION; BIOAVAILABILITY; DRUG ANTAGONISM; FOOD DRUG INTERACTION; GRAPEFRUIT; HERB DRUG INTERACTION; HUMAN; HYPERICUM; LIVER; METABOLISM; OXIDATION REDUCTION REACTION;

BINDING, COMPETITIVE; BIOLOGICAL AVAILABILITY; CITRUS PARADISI; CYTOCHROME P-450 ENZYME SYSTEM; FLAVONOIDS; FOOD-DRUG INTERACTIONS; HERB-DRUG INTERACTIONS; HUMANS; HYPERICUM; HYPNOTICS AND SEDATIVES; LIVER; OXIDATION-REDUCTION; P-GLYCOPROTEIN; PSORALENS;

EID: 25144522303     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Bailey DG, Spence JD, Edgar B, Bayliff CD, Arnold JM. Ethanol enhances the hemodynamic effects of felodipine. Clin Investig Med 1989;12:357-362.
2. Karch AM. The grapefruit challenge: The juice inhibits a crucial enzyme, with possibly fatal consequences. Amer J Nurs 2004;104:33-35.
3. Bailey DG, Dresser GK. Natural products and adverse drug interactions. CMAJ 2004;170:1531-1532.
4. Flynn TR, Halpern LR. Antibiotic selection in head and neck infections. Oral Maxillofac Surg 2003;15:17-34.
5. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W, Watkins PB. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 1997;99:2545-2553.
6. Bailey DG, Dresser GK. Interactions between grapefruit juice and cardiovascular drugs. Am J Cardiovasc Drugs 2004;4:281-297.
7. Lilja JJ, Kivisto KT, Neuvonen PJ. Grapefruit juice increases serum concentrations of atrovastatin and has no effect on pravastatin. Clin Pharmacol Ther 1999;66:118-127.
8. Bailey DG, Bend JR, Arnold JM, Tran LT, Spence JD. Erythromycin- felodipine interaction: Magnitude, mechanism, and comparison with grapefruit juice. Clin Pharmacol Ther 1996;60:25-33.
9. Merry C, Barry MG, Mulcahy F, Ryan M, Heavey J, Tjia JF, Gibbons SE, Breckenridge AM, Back DJ. Saquinavir pharmacokinetics alone and in combination with ritonavir in HIV-infected patients. AIDS 1997;11:F29-33.
10. Odou P, Ferrari N, Barthelemy C, Brique S, Lhermitte M, Vincent A, Libersa C, Robert H. Grapefruit juice-nifedipine interaction: Possible involvement of several mechnisms. J Clin Pharm Ther 2005;30:153-158.
11. Bailey DG, Dresser GK, Bend JR. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice. Clin Pharmacol Ther 2003;73:529-537.
12. Bailey DG, Malcolm J, Arnold O, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46:101-110.
13. Sadeque AJ, Wandel C, He H, Shah S, Wood AJ. Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther 2000;68:231-237.
14. Ernst E. Second thoughts about the safety of St. John's wort. Lancet 1999;354:2014-2016.
15. Flanagan D. Oral triazolam sedation in implant dentistry. J Oral Implantol 2004;30:93-97.